vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and T1 Energy Inc. (TE). Click either name above to swap in a different company.
T1 Energy Inc. is the larger business by last-quarter revenue ($210.5M vs $196.0M, roughly 1.1× Axsome Therapeutics, Inc.). Axsome Therapeutics, Inc. runs the higher net margin — -14.6% vs -62.0%, a 47.4% gap on every dollar of revenue. T1 Energy Inc. produced more free cash flow last quarter ($55.0M vs $-18.7M).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Sony Energy Devices Corporation , is a Japanese multinational company specializing in a variety of areas in the energy industry, and is a wholly owned subsidiary and part of the Devices Group of Sony. The company was established in February 1975 in Fukushima, Japan.
AXSM vs TE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $210.5M |
| Net Profit | $-28.6M | $-130.6M |
| Gross Margin | — | 10.0% |
| Operating Margin | -13.8% | -45.0% |
| Net Margin | -14.6% | -62.0% |
| Revenue YoY | 65.0% | — |
| Net Profit YoY | 61.9% | -375.2% |
| EPS (diluted) | $-0.55 | $-0.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | — | ||
| Q3 25 | $171.0M | $210.5M | ||
| Q2 25 | $150.0M | $132.8M | ||
| Q1 25 | $121.5M | $53.5M | ||
| Q4 24 | $118.8M | — | ||
| Q3 24 | $104.8M | $0 | ||
| Q2 24 | $87.2M | $0 | ||
| Q1 24 | $75.0M | $0 |
| Q4 25 | $-28.6M | — | ||
| Q3 25 | $-47.2M | $-130.6M | ||
| Q2 25 | $-48.0M | $-31.9M | ||
| Q1 25 | $-59.4M | $-16.2M | ||
| Q4 24 | $-74.9M | — | ||
| Q3 24 | $-64.6M | $-27.5M | ||
| Q2 24 | $-79.3M | $-27.0M | ||
| Q1 24 | $-68.4M | $-28.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | 10.0% | ||
| Q2 25 | — | 24.7% | ||
| Q1 25 | — | 33.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -13.8% | — | ||
| Q3 25 | -27.0% | -45.0% | ||
| Q2 25 | -24.5% | -22.0% | ||
| Q1 25 | -46.9% | -44.2% | ||
| Q4 24 | -61.1% | — | ||
| Q3 24 | -59.8% | — | ||
| Q2 24 | -89.5% | — | ||
| Q1 24 | -89.7% | — |
| Q4 25 | -14.6% | — | ||
| Q3 25 | -27.6% | -62.0% | ||
| Q2 25 | -32.0% | -24.0% | ||
| Q1 25 | -48.9% | -30.4% | ||
| Q4 24 | -63.1% | — | ||
| Q3 24 | -61.7% | — | ||
| Q2 24 | -91.0% | — | ||
| Q1 24 | -91.1% | — |
| Q4 25 | $-0.55 | — | ||
| Q3 25 | $-0.94 | $-0.87 | ||
| Q2 25 | $-0.97 | $-0.21 | ||
| Q1 25 | $-1.22 | $-0.11 | ||
| Q4 24 | $-1.54 | — | ||
| Q3 24 | $-1.34 | $-0.20 | ||
| Q2 24 | $-1.67 | $-0.19 | ||
| Q1 24 | $-1.44 | $-0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $34.1M |
| Total DebtLower is stronger | — | $547.3M |
| Stockholders' EquityBook value | $88.3M | $96.9M |
| Total Assets | $689.8M | $1.4B |
| Debt / EquityLower = less leverage | — | 5.65× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | — | ||
| Q3 25 | $325.3M | $34.1M | ||
| Q2 25 | $303.0M | $8.5M | ||
| Q1 25 | $300.9M | $48.9M | ||
| Q4 24 | $315.4M | — | ||
| Q3 24 | $327.3M | $181.9M | ||
| Q2 24 | $315.7M | $219.6M | ||
| Q1 24 | $331.4M | $249.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | $547.3M | ||
| Q2 25 | — | $591.2M | ||
| Q1 25 | — | $603.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $602.3M |
| Q4 25 | $88.3M | — | ||
| Q3 25 | $73.7M | $96.9M | ||
| Q2 25 | $73.1M | $183.9M | ||
| Q1 25 | $53.2M | $201.9M | ||
| Q4 24 | $57.0M | — | ||
| Q3 24 | $92.9M | $538.7M | ||
| Q2 24 | $102.9M | $561.6M | ||
| Q1 24 | $144.0M | $582.3M |
| Q4 25 | $689.8M | — | ||
| Q3 25 | $669.3M | $1.4B | ||
| Q2 25 | $639.8M | $1.4B | ||
| Q1 25 | $596.7M | $1.4B | ||
| Q4 24 | $568.5M | — | ||
| Q3 24 | $561.5M | $615.0M | ||
| Q2 24 | $548.2M | $644.4M | ||
| Q1 24 | $545.7M | $670.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | 5.65× | ||
| Q2 25 | — | 3.21× | ||
| Q1 25 | — | 2.99× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $63.9M |
| Free Cash FlowOCF − Capex | $-18.7M | $55.0M |
| FCF MarginFCF / Revenue | -9.6% | 26.1% |
| Capex IntensityCapex / Revenue | 0.0% | 4.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $-42.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $1.0M | $63.9M | ||
| Q2 25 | $-32.4M | $33.4M | ||
| Q1 25 | $-43.4M | $-44.8M | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $-18.6M | $-28.4M | ||
| Q2 24 | $-30.1M | $-28.0M | ||
| Q1 24 | $-53.5M | $-16.2M |
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $988.0K | $55.0M | ||
| Q2 25 | $-32.4M | $10.6M | ||
| Q1 25 | $-43.7M | $-74.0M | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $-18.7M | $-34.0M | ||
| Q2 24 | $-30.2M | $-35.6M | ||
| Q1 24 | $-53.6M | $-37.7M |
| Q4 25 | -9.6% | — | ||
| Q3 25 | 0.6% | 26.1% | ||
| Q2 25 | -21.6% | 8.0% | ||
| Q1 25 | -36.0% | -138.4% | ||
| Q4 24 | -22.1% | — | ||
| Q3 24 | -17.9% | — | ||
| Q2 24 | -34.6% | — | ||
| Q1 24 | -71.4% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 4.2% | ||
| Q2 25 | 0.0% | 17.2% | ||
| Q1 25 | 0.3% | 54.5% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
TE
| Related Party | $120.1M | 57% |
| Nonrelated Party | $90.4M | 43% |
